Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LOX | P28300 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | F13A1 | P00488 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | GLP1R | P43220 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Magnesium SCHEMBL31484747 | 0.98 | KDM4E (0.54) | KDM4EMAPK1HIF1APAOXTSHR | |
| SCHEMBL28485860 | 0.98 | KDM4E (0.54) | KDM4EMAPK1HIF1APAOXTSHR | |
| Calcium SCHEMBL2590651 | 0.98 | KDM4E (0.54) | KDM4EMAPK1HIF1APAOXTSHR | |
| Water SCHEMBL926831 | 0.98 | KDM4E (0.54) | KDM4EMAPK1HIF1APAOXTSHR | |
| SCHEMBL2780184 | 0.98 | KDM4E (0.54) | KDM4EMAPK1HIF1APAOXTSHR | |
| Water SCHEMBL31512214 | 0.95 | KDM4E (0.52) | KDM4EMAPK1HIF1APAOXTSHR | |
| Water SCHEMBL31512216 | 0.95 | KDM4E (0.52) | KDM4EMAPK1HIF1APAOXTSHR | |
| Water SCHEMBL927462 | 0.95 | KDM4E (0.52) | KDM4EMAPK1HIF1APAOXTSHR | |
| SCHEMBL17754088 | 0.86 | KDM4E (0.65) | KDM4EMAPK1HIF1APAOXTSHR | |
| Acamprosate SCHEMBL41983 | 0.86 | KDM4E (0.65) | KDM4EMAPK1HIF1APAOXTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087536-A1 | METHODS OF USING HOMOTAURINE AND ANALOGS THEREOF FOR THE TREATMENT OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST INDUCED GASTROINTESTINAL SIDE EFFECTS | UNIVERSITY OF TARTU (EE) | 2026-04-30 | — | — | WO | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260034171-A1 | Composition for Improving Cognitive Function | PERRY STEPHEN C (US) | 2026-02-05 | — | — | US | claimed |
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| CN-119504517-B | Preparation method of magnesium acetyltaurate | 浙江天启生化股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119751315-A | Method for preparing acetyltaurine calcium salt and other acetyltaurine salts | 苏州满元生物科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-119504517-A | Preparation method of magnesium acetyltaurate | 浙江天启生化股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119431198-A | Preparation method of magnesium acetyltaurate | 苏州满元生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119074711-A | Application of N-lactoyl phenylalanine and N-acetyltaurine in preparation of multifunctional therapeutic drugs | 广东药科大学 | 2024-12-06 | — | — | CN | claimed |
| US-20030229122-A1 | Use of methylphenidate compounds to enhance memory | SENTION, INC. | 2003-12-11 | — | — | US | claimed |
| WO-2003060099-A2 | METHODS AND APPARATUS FOR SPINNING SPIDER SILK PROTEIN | NEXIA BIOTECHNOLOGIES, INC. (CA) | 2003-07-24 | — | — | WO | claimed |
| EP-1315495-A2 | USE OF THREO-METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY | Sention, Inc. (US) | 2003-06-04 | — | — | EP | claimed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | claimed |
| US-20020132793-A1 | Use of methylphenidate compounds to enhance memory | SENTION INC. | 2002-09-19 | — | — | US | claimed |
| US-20020103162-A1 | Use of threo-methylphenidate compounds to enhance memory | SENTION, INC. | 2002-08-01 | — | — | US | claimed |
| WO-2002017920-A2 | USE OF METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY | SENTION, INC (US) | 2002-03-07 | — | — | WO | claimed |
| WO-2002017919-A2 | USE OF THREO-METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY | SENTION, INC. (US) | 2002-03-07 | — | — | WO | claimed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034171-A1 | Composition for Improving Cognitive Function | PHOSPHO1, PSEN1, S100B | KDM4E 3027/4885MAPK1 1966/4885HIF1A 3863/4885 |
| US-20020132793-A1 | Use of methylphenidate compounds to enhance memory | PNMT, CHAT, SLC6A3 | KDM4E 237/4885MAPK1 734/4885HIF1A 4006/4885 |
| US-20020103162-A1 | Use of threo-methylphenidate compounds to enhance memory | SLC6A3, SLC6A2, PNMT | KDM4E 437/4885MAPK1 450/4885HIF1A 4257/4885 |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | KDM4E 124/4885MAPK1 1697/4885HIF1A 37/4885 |
| US-20030229122-A1 | Use of methylphenidate compounds to enhance memory | PNMT, GRIN3B, GRIN3A | KDM4E 335/4885MAPK1 354/4885HIF1A 4061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.